Identification of a peptide inhibitor for the histone methyltransferase WHSC1-Reference-Cited by-同舟云学术

Identification of a peptide inhibitor for the histone methyltransferase WHSC1

Published:2018-05-09 Issue:5 Volume:13 Page:e0197082
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Morrison Michael J.^ORCID,Boriack-Sjodin P. Ann,Swinger Kerren K.,Wigle Tim J.,Sadalge Dipti,Kuntz Kevin W.,Scott Margaret Porter,Janzen William P.,Chesworth Richard,Duncan Kenneth W.,Harvey Darren M.,Lampe John W.,Mitchell Lorna H.,Copeland Robert A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Chromatin modifications and their function;T Kouzarides;Cell,2007

2. Epigenetic protein families: a new frontier for drug discovery;CH Arrowsmith;Nat Rev Drug Discov,2012

3. Drug Discovery and Chemical Biology of Cancer Epigenetics;S Ribich;Cell Chem Biol,2017

4. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate;Y Li;J Biol Chem,2009

5. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming;AJ Kuo;Mol Cell,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations;PLOS ONE;2024-08-20

2. NSD family proteins: Rising stars as therapeutic targets;Cell Insight;2024-04

3. Structural insights into the C-terminus of the histone-lysine N-methyltransferase NSD3 by small-angle X-ray scattering;Frontiers in Molecular Biosciences;2024-03-07

4. Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs;European Journal of Medicinal Chemistry;2024-03

5. Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2);Journal of Medicinal Chemistry;2023-08-14